RL
CRL icon

Rogco LP’s Charles River Laboratories CRL Stock Holding History

Rogco LP’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-81
Closed -$12.3K – 199
2025
Q2 		$12.3K Hold
81
– – ﹤0.01% 159
2025
Q1 		$12.2K Hold
81
– – ﹤0.01% 162
2024
Q4 		$15K Hold
81
– – 0.01% 156
2024
Q3 		$16K Hold
81
– – 0.01% 156
2024
Q2 		$16.7K Buy
+81
New +$18.4K 0.01% 155

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rogco LP's CRL Position: Q3 2025 in Review

Rogco LP sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 81 shares — an estimated $12.3K sold.

Rogco LP first reported a position in CRL in Q2 2024 and held it in 5 quarters. The position peaked at $16.7K in Q2 2024. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Rogco LP reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Rogco LP sold 81 Charles River Laboratories shares in Q3 2025, an estimated $12.3K.
  • Rogco LP first reported a position in Charles River Laboratories in Q2 2024 and held it in 5 quarters.
  • Rogco LP's Charles River Laboratories position peaked at $16.7K in Q2 2024.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Rogco LP's 13F filing for Q3 2025, filed 30 Oct 2025.